Literature DB >> 34083033

A systematic review of long non-coding RNAs with a potential role in breast cancer.

Reza Heidari1, Mostafa Akbariqomi2, Yazdan Asgari3, Diako Ebrahimi4, Hamid Alinejad-Rokny5.   

Abstract

The human transcriptome contains many non-coding RNAs (ncRNAs), which play important roles in gene regulation. Long noncoding RNAs (lncRNAs) are an important class of ncRNAs with lengths between 200 and 200,000 bases. Unlike mRNA, lncRNA lacks protein-coding features, specifically, open-reading frames, and start and stop codons. LncRNAs have been reported to play a role in the pathogenesis and progression of many cancers, including breast cancer (BC), acting as tumor suppressors or oncogenes. In this review, we systematically mined the literature to identify 65 BC-related lncRNAs. We then perform an integrative bioinformatics analysis to identify 14 lncRNAs with a potential regulatory role in BC. The biological function of these 14 lncRNAs, their regulatory mechanisms, and roles in the initiation and progression of BC are discussed in this review. Additionally, we elaborate on the current and future applications of lncRNAs as diagnostic and/or therapeutic biomarkers in BC.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; Causative lncRNAs; Gene prioritization; Gene regulation; Long non-coding RNA; Therapeutic biomarkers

Year:  2021        PMID: 34083033     DOI: 10.1016/j.mrrev.2021.108375

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  4 in total

1.  A Survey on Machine Learning and Internet of Medical Things-Based Approaches for Handling COVID-19: Meta-Analysis.

Authors:  Shahab S Band; Sina Ardabili; Atefeh Yarahmadi; Bahareh Pahlevanzadeh; Adiqa Kausar Kiani; Amin Beheshti; Hamid Alinejad-Rokny; Iman Dehzangi; Arthur Chang; Amir Mosavi; Massoud Moslehpour
Journal:  Front Public Health       Date:  2022-06-23

2.  Somatic point mutations are enriched in non-coding RNAs with possible regulatory function in breast cancer.

Authors:  Narges Rezaie; Masroor Bayati; Mehrab Hamidi; Maedeh Sadat Tahaei; Sadegh Khorasani; Nigel H Lovell; James Breen; Hamid R Rabiee; Hamid Alinejad-Rokny
Journal:  Commun Biol       Date:  2022-06-07

3.  MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification.

Authors:  Wenjing Shi; Yongzhe Tang; Jing Lu; Yihui Zhuang; Jie Wang
Journal:  Cell Biosci       Date:  2022-03-28       Impact factor: 7.133

4.  Integrative analysis of mutated genes and mutational processes reveals novel mutational biomarkers in colorectal cancer.

Authors:  Hamed Dashti; Iman Dehzangi; Masroor Bayati; James Breen; Amin Beheshti; Nigel Lovell; Hamid R Rabiee; Hamid Alinejad-Rokny
Journal:  BMC Bioinformatics       Date:  2022-04-19       Impact factor: 3.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.